Pharmaceutical companies launch weight loss pills after injection success

Pharmaceutical companies Novo Nordisk and Eli Lilly are moving towards oral formulations of anti-obesity medications, following the success of their injectable therapies. This decision comes as these companies seek to expand their range of treatments for people suffering from obesity.

Following a successful launch in the American market, these companies are now preparing to introduce their new products in additional countries, marking an important step in the development of solutions against obesity.